BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical's GHG Emissions Data Preview
In 2022, BioMarin Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, BioMarin Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2022 | 2021 | 2020 | 2019 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. a | 0000000 |
Total Scope 2 | ||||
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind BioMarin Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BioMarin Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into BioMarin Pharmaceutical's Operational Emissions
In 2022, the total operational greenhouse gas (GHG) emissions of BioMarin Pharmaceutical amounted to 23,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
0BioMarin Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are BioMarin Pharmaceutical's Scope 1 emissions?
In 2022, the total Scope 1 emissions of BioMarin Pharmaceutical were 14,000 metric tons of CO₂ equivalent (tCO₂e). a
Has BioMarin Pharmaceutical reduced its Scope 1 emissions over time?
Since 2020, BioMarin Pharmaceutical's Scope 1 emissions have decreased by 6.67%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2021), BioMarin Pharmaceutical's Scope 1 emissions decreased by 6.67%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are BioMarin Pharmaceutical's Scope 2 emissions?
In 2022, BioMarin Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 9,000 tCO₂e using the location-based method. a
Has BioMarin Pharmaceutical reduced its Scope 2 emissions over time?
Since 2020, BioMarin Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 28.57%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2021), BioMarin Pharmaceutical's Scope 2 emissions (Location-Based) rose by 12.5% in 2022, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does BioMarin Pharmaceutical use for Scope 2 reporting?
In 2022, BioMarin Pharmaceutical reported its Scope 2 emissions using the location-based method. a
BioMarin Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based